definiens: shall mean the specific HApTM Marker or the specific group or combination of HApTM Markers ( j ) directly resulting from the Research Project that led to the discovery ~ HApTM Marker Association, ( m such other HApTM Markers as [COMPANY] may nominate, subject to [COMPANY] ' s approval, as reasonably necessary to exploit the selected HApTM Marker Association and ( iii ) any sub - combination thereof which contains fewer HApTM Markers than the combination described in the foregoing subsections ( j ) or ( m, provided that . with respect to any generic drug that is not marketed by [COMPANY], any HApTM Marker Combination containing a HApTM Marker that is not within the scope of ( j ) . ( m, and ( iii ) above shall not be considered to be licensed to [COMPANY] hereunder . It is understood that [COMPANY] shall provide a reasonable basis in writing for the HApTM Marker(s ) not to be included in the HApTM Marker Combination under ( m above . In the event the parties can not agree upon the HApTM Marker Combination under ( m above within thirty ( 30 ) days after receipt of written notification of [COMPANY] by JanSsen of the other HApTM Markers reasonably necessary to exploit the HApTM Marker Association under this Section 2.1.3 . the matter shall be resolved by dispute resolution pursuant to Section 10.6